MRI does not reliably exclude clinically significant prostate cancer in about one quarter of patients receiving active surveillance, confirming that MRI is not a substitute for biopsy.

MRI system significantly improves prostate cancer detection and efficiency. Find out how ProAI boosts accuracy and reduces ...

Multiparametric MRI detects more local recurrences after prostatectomy than prostate-specific membrane antigen PET-CT, with the two showing only moderate agreement.

Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...

Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as ...